Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
147M
-
Number of holders
-
993
-
Total 13F shares, excl. options
-
159M
-
Shares change
-
-6.6M
-
Total reported value, excl. options
-
$37.3B
-
Value change
-
-$1.55B
-
Put/Call ratio
-
1.32
-
Number of buys
-
377
-
Number of sells
-
-580
-
Price
-
$233.87
Significant Holders of BIOGEN INC. - Common Stock (BIIB) as of Q2 2019
1,206 filings reported holding BIIB - BIOGEN INC. - Common Stock as of Q2 2019.
BIOGEN INC. - Common Stock (BIIB) has 993 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 159M shares
.
Largest 10 shareholders include BlackRock Inc. (16M shares), VANGUARD GROUP INC (14.8M shares), PRIMECAP MANAGEMENT CO/CA/ (14.6M shares), STATE STREET CORP (8.76M shares), Clearbridge Investments, LLC (6.28M shares), Capital World Investors (4.07M shares), WELLINGTON MANAGEMENT GROUP LLP (3.8M shares), AQR CAPITAL MANAGEMENT LLC (3.79M shares), GEODE CAPITAL MANAGEMENT, LLC (3.29M shares), and Invesco Ltd. (2.99M shares).
This table shows the top 993 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.